Security key
75886F107
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 92,906,259
- Total 13F value
- $64,040,087,013
- Share change
- -306,137
- Put/Call ratio
- 130%
- SEC-reported price per share
- $688.87
- Number of holders
- 1,066
- Value change
- -$168,708,759
- Number of buys
- 466
- Number of sells
- 501
- Shares outstanding
- 103,945,862
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
1,066
Top holders
10
REGN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2022
Previous quarter: Q2 2022
REGENERON PHARMACEUTICALS, INC. SEC filings
REGENERON PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75886F107
Recent filing periods:
Ownership snapshot
Top reported holders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 9.8%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 9.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
9.8%
BlackRock Finance, Inc.
9.1%
VANGUARD GROUP INC
8.2%
Capital World Investors
6%
JPMORGAN CHASE & CO
5.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
9.8%
|
$6,015,457,000
10,176,199 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
9.1%
|
$5,608,694,000
9,488,090 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
8.2%
|
$5,066,425,000
8,570,745 shares
|
— | 30 Jun 2022 |
| Capital World Investors |
13F
Company
|
6%
|
$3,685,500,000
6,234,611 shares
|
— | 30 Jun 2022 |
| JPMORGAN CHASE & CO |
13F
Company
|
5.5%
|
$3,356,691,000
5,678,432 shares
|
— | 30 Jun 2022 |
| STATE STREET CORP |
13F
Company
|
4.9%
|
$3,032,872,000
5,130,635 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,066
Shares
92,906,259
Rows available
1,066
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
1,053
Q3 2022 holders
1,066
Holder diff
13
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend